Mechanistic studies of intramembrane protease GlpG

膜内蛋白酶GlpG的机理研究

基本信息

  • 批准号:
    9193640
  • 负责人:
  • 金额:
    $ 33.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-01-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): A long-term objective of our research is to clarify the mechanism of rhomboid intramembrane proteases. Rhomboids are integral membrane proteins and represent an ancient and widespread enzyme family. During the course of evolution rhomboids have acquired many different biological functions, many of which are important in biology and medicine. For example, in P. falciparum, the parasite that causes malaria, rhomboid proteases play an essential role in the invasion of human host cells. We have previously determined the x-ray structures of E. coli rhomboid GlpG and its complexes with mechanism-specific inhibitors. In this application we continue to use GlpG as a model system to investigate how rhomboid interacts with TM substrate. Three specific aims are proposed. In aim 1, we test the hypothesis that substrate's TM domain docks onto an exosite on GlpG and induces a conformational change that activates the protease. Crystal structures of activity- enhancing mutants and the complex between GlpG and substrate's TM domain will be solved to explain the nature of the allosteric transition. In aim 2, cysteine accessibility and optical tweezers experiments are planned to investigate the unfolding of substrate's TM domain, a prerequisite for the intramembrane cleavage reaction. In aim 3, building on the discovery of diisopropyl fluorophosphate as a covalent inhibitor for GlpG, two types of peptidomimetics incorporating reactive phosphonate groups will be synthesized to prepare stable complexes with GlpG for x-ray analysis. Mutagenesis and functional experiments are also planned to explain rhomboid's substrate specificity.
 描述(由申请人提供):我们研究的一个长期目标是阐明菱形膜内酶的机制。菱形是一种完整的膜蛋白,代表着一个古老而广泛的酶家族。在进化过程中,菱形获得了许多不同的生物学功能,其中许多在生物学和医学上都很重要。例如,在导致疟疾的恶性疟原虫中,菱形蛋白水解酶在人类宿主细胞的入侵中起着至关重要的作用。我们以前已经测定了大肠杆菌菱形GlpG及其与机制特异性抑制剂的络合物的X射线结构。在这个应用中,我们继续使用GlpG作为模型系统来研究菱形如何与TM底物相互作用。提出了三个具体目标。在目标1中,我们测试了底物的TM结构域对接到GlpG上的外显子上并诱导激活蛋白酶的构象变化的假设。活性增强突变体的晶体结构和GlpG与底物TM结构域之间的复合体将被解决,以解释变构转变的本质。在目标2中,计划进行半胱氨酸可及性和光钳实验,以研究底物TM结构域的展开,这是膜内切割反应的先决条件。在目标3,在发现二异丙基氟磷酸盐作为GlpG共价抑制剂的基础上,合成了两种含有反应性膦酸基的肽类化合物,以制备稳定的GlpG配合物,用于X-射线分析。还计划进行诱变和功能实验来解释菱形的底物专一性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YA HA其他文献

YA HA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YA HA', 18)}}的其他基金

The biochemical mechanism and pharmacological inhibition of phosphatidylinositol phosphate kinases
磷脂酰肌醇磷酸激酶的生化机制及药理抑制作用
  • 批准号:
    10711064
  • 财政年份:
    2023
  • 资助金额:
    $ 33.5万
  • 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
  • 批准号:
    10260471
  • 财政年份:
    2020
  • 资助金额:
    $ 33.5万
  • 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
  • 批准号:
    10387119
  • 财政年份:
    2020
  • 资助金额:
    $ 33.5万
  • 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
  • 批准号:
    10427407
  • 财政年份:
    2020
  • 资助金额:
    $ 33.5万
  • 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
  • 批准号:
    10033704
  • 财政年份:
    2020
  • 资助金额:
    $ 33.5万
  • 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
  • 批准号:
    10652413
  • 财政年份:
    2020
  • 资助金额:
    $ 33.5万
  • 项目类别:
Structural Studies of GxGD Membrane Protease FlaK
GxGD 膜蛋白酶 FlaK 的结构研究
  • 批准号:
    8437932
  • 财政年份:
    2013
  • 资助金额:
    $ 33.5万
  • 项目类别:
CRYSTALLOGRAPHIC ANALYSIS OF A BACTERIAL MEMBRANE PROTEASE
细菌膜蛋白酶的晶体分析
  • 批准号:
    8361662
  • 财政年份:
    2011
  • 资助金额:
    $ 33.5万
  • 项目类别:
CRYSTALLOGRAPHIC ANALYSIS OF A BACTERIAL MEMBRANE PROTEASE
细菌膜蛋白酶的晶体分析
  • 批准号:
    8169303
  • 财政年份:
    2010
  • 资助金额:
    $ 33.5万
  • 项目类别:
Structural studies of intramembrane protease GlpG
膜内蛋白酶GlpG的结构研究
  • 批准号:
    8141468
  • 财政年份:
    2010
  • 资助金额:
    $ 33.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了